Back
Adaptimmune Therapeutics PLC Stock Price Chart
The AI Energy Miracle
Details Here.
Sell
20
ADAP
Adaptimmune Therapeutics PLC
Last Price:
$0.60
Seasonality Move:
36.97%
7 Day Trial
ALL ACCESS PASS
$
7
These 7 Stocks Will Be Magnificent in 2025
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.-
The current trend is relatively stagnant and ADAP is experiencing slight buying pressure.
Adaptimmune Therapeutics PLC Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.61 | Sell |
| 20-day SMA: | 0.65 | Sell |
| 50-day SMA: | 0.72 | Sell |
| 200-day SMA: | 1.04 | Sell |
| 8-day EMA: | 0.61 | Sell |
| 20-day EMA: | 0.64 | Sell |
| 50-day EMA: | 0.73 | Sell |
| 200-day EMA: | 0.93 | Sell |
Adaptimmune Therapeutics PLC Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 38.3 | Sell |
| Chaikin Money Flow: | 3030174 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.6 - 0.7) | Sell |
| Bollinger Bands (100): | (0.69 - 1.09) | Sell |
Adaptimmune Therapeutics PLC Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Adaptimmune Therapeutics PLC Stock
Is Adaptimmune Therapeutics PLC Stock a Buy?
-
Adaptimmune Therapeutics PLC share price is 0.60 while ADAP 8-day simple moving average is 0.61, which is a Sell signal.
-
The stock price of ADAP is 0.60 while Adaptimmune Therapeutics PLC 20-day SMA is 0.65, which makes it a Sell.
-
Adaptimmune Therapeutics PLC 50-day simple moving average is 0.72 while ADAP share price is 0.60, making it a Sell technically.
-
ADAP stock price is 0.60 and Adaptimmune Therapeutics PLC 200-day simple moving average is 1.04, creating a Sell signal.
ADAP Technical Analysis vs Fundamental Analysis
Sell
20
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy or a Sell?
-
Adaptimmune Therapeutics PLC stock is rated a SellThe current Adaptimmune Therapeutics PLC [ADAP] share price is $0.60. The Score for ADAP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Adaptimmune Therapeutics PLC Stock Info
Market Cap:
154.8M
Price in USD:
0.60
Share Volume:
3.1M
Adaptimmune Therapeutics PLC 52-Week Range
52-Week High:
2.05
52-Week Low:
0.47
Sell
20
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Adaptimmune Therapeutics PLC Share Price Forecast
-
What is the Adaptimmune Therapeutics PLC stock price today?The Adaptimmune Therapeutics PLC stock price is 0.60 USD today.
-
Will ADAP stock go up or go down?Adaptimmune Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators
-
Is Adaptimmune Therapeutics PLC overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Adaptimmune Therapeutics PLC is overvalued.
Is Adaptimmune Therapeutics PLC Stock a Buy?
-
Adaptimmune Therapeutics PLC share price is 0.60 while ADAP 8-day exponential moving average is 0.61, which is a Sell signal.
-
The stock price of ADAP is 0.60 while Adaptimmune Therapeutics PLC 20-day EMA is 0.64, which makes it a Sell.
-
Adaptimmune Therapeutics PLC 50-day exponential moving average is 0.73 while ADAP share price is 0.60, making it a Sell technically.
-
ADAP stock price is 0.60 and Adaptimmune Therapeutics PLC 200-day simple moving average is 0.93, creating a Sell signal.
Fundamental Analysis of Adaptimmune Therapeutics PLC
Is Adaptimmune Therapeutics PLC a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and a decrease next year of $0.33 per share.
Technical Analysis of Adaptimmune Therapeutics PLC
Should I short Adaptimmune Therapeutics PLC stock?
-
ADAP Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Adaptimmune Therapeutics PLC is a Sell
-
Adaptimmune Therapeutics PLC Relative Strength Index (RSI) is 38.3, which suggest Adaptimmune Therapeutics PLC is oversold
-
The Bollinger Bands (25) for Adaptimmune Therapeutics PLC is (0.6 - 0.7), which suggest Adaptimmune Therapeutics PLC is a Sell
-
The Bollinger Bands (100) for Adaptimmune Therapeutics PLC is (0.69 - 1.09), which suggest Adaptimmune Therapeutics PLC is a Sell
* Adaptimmune Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.